• Fri. Nov 22nd, 2024

Month: January 2023

  • Home
  • Aterian: Paving The Way For An Improved Second Half, Buy (NASDAQ:ATER)

Aterian: Paving The Way For An Improved Second Half, Buy (NASDAQ:ATER)

[ad_1] Abdullah Durmaz/iStock via Getty Images For a second quarter in a row now, e-commerce brand consolidator Aterian (NASDAQ:ATER) reported preliminary sales well ahead of consensus expectations as the company…

Cancer Genomics-Focused Personalis To Reduce Nearly One-Third Of Its Workforce

[ad_1] Personalis Inc PSNL approved a reduction in the company’s workforce by up to approximately 30% to reduce operating costs and improve operating efficiency.  The reduction in workforce is expected to…

BofA Downgrades Levi Strauss On Cautious North America Outlook

[ad_1] BofA Securities analyst downgraded Levi Strauss & Co LEVI from Buy to Neutral and lowered the price target from $19 to $17. The analyst remains wary that the highly promotional environment…

Sunak dare not be seen at Davos

[ad_1] This article is an on-site version of our Inside Politics newsletter. Sign up here to get the newsletter sent straight to your inbox every weekday Good morning. Keir Starmer…

Russia May Lose $150B On Sanctions, Urals Discount: Analyst

[ad_1] As the West implemented sanctions on Russia, including the oil price cap of $60 per barrel, in the backdrop of the Ukraine war, the country has reportedly lost over…